Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-23T23:24:26.950Z Has data issue: false hasContentIssue false
  • English
  • Français

Experience with Ommaya Reservoir in 120 Consecutive Patients with Meningeal Malignancy

Published online by Cambridge University Press:  18 September 2015

R.G. Perrin ,
M. Lishner ,
A. Guha ,
J. Curtis ,
R. Feld  and
H. Messner
R.G. Perrin*
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
M. Lishner
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
A. Guha
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
J. Curtis
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
R. Feld
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
H. Messner
Affiliation:
Department of Neurological Surgery, The Wellesley Hospital, Toronto
*
160 Wellesley Street East, Suite 314, Jones Building, Toronto, Ontario, Canada M4Y 1J3
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Ommaya Reservoir plays an important role in a select group of neuro-oncology patients with meningeal malignancy. The benefits derived must be balanced against potential complications associated with insertion and use of the apparatus. Side effects may be minimized by careful attention to patient selection, pre-operative CAT scan (or MRI), precise surgical technique, perioperative prophylactic antibiotics and meticulous procedure during use of the reservoir.

Résumé:

RÉSUMÉ:

Le réservoir d'Òmmaya joue un rôle important en neuro-oncologie chez un groupe sélectionné de patients atteints de néoplasie méningée. Les bénéfices escomptés doivent être pesés en regard des complications possibles associées avec la mise en place et l'utilisation de ce dispositif. Les effets secondaires peuvent être minimisés par un choix judicieux des patients, un CAT scan pré-opératoire (ou MRI), une technique chirurgicale précise, une antibiothérapie péri-opératoire prophylactique et une procédure méticuleuse pendant l'utilisation du réservoir.

Type
Neurosurgical Symposium - William S. Keith, Visiting Professorship in Neurosurgery
Information
Canadian Journal of Neurological Sciences , Volume 17 , Issue 2 , May 1990 , pp. 190 - 192
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1. Ommaya, AK. Subcutaneous reservoir and pump for sterile access to ventricular CSF. Neurol 1985; 35: 1274–1278.Google Scholar
2. Bleyer, WA, Pizzo, PA, Spence, AM, et al. The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer 1978; 41: 2431–2437.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
3. Reiselbach, RE, Dichino, G, Freireich, EJ. Subarachnoid distribution of drugs after lumbar injection. New England J Med 1962; 267: 1273.CrossRefGoogle Scholar
4. Galicich, JJ, Guido, LJ. Ommaya device in carcinomatous and leukaemic meningitis: surgical experience in 45 cases. Surg Clin N Am 1974; 54: 915–922.CrossRefGoogle Scholar
5. Jacobs, A, Clifford, P, Kay, HEM. The Ommaya reservoir in chemotherapy for malignant disease in the CNS. Clin Oncol 1981; 7: 123–129.Google ScholarPubMed
6. Ratcheson, RA, Ommaya, AK. Experience with the subcutaneous cerebrospinal fluid reservoir. New England J Med 1968; 279: 1025–1031.CrossRefGoogle ScholarPubMed
7. Machado, M, Salcman, M, Kaplan, RS, et al. Expanded role of the cerebrospinal fluid reservoir in neuro-oncology: indications, causes of revision, and complications. Neurosurgery 1985; 17: 600–603.CrossRefGoogle Scholar
8. Obens, EAMT, Leavens, ME, Beal, JN, et al. Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 1985; 35: 1274–1278.CrossRefGoogle Scholar
9. Bleyer, WA, Poplack, DG. Intraventricular versus intralumbar methotrexate for central nervous system leukaemia: prolonged remission with Ommaya reservoir. Medical and Paediatric Oncology 1979; 6: 207–213.CrossRefGoogle ScholarPubMed
10. Gribbin, JA, Hardisdy, RM, Chessells, JM. Long-term control of cen-tral nervous system leukaemia. Arch Dis Childhood 1977; 52: 673–678.CrossRefGoogle Scholar
11. Connors, JM. Cure of Ommaya reservoir associated staphylococcus epideridis ventriculitis with a simple regimen of vancomycin and rifampin without reservoir removal. Med and Paed Oncol 1982; 10: 549–552.CrossRefGoogle ScholarPubMed